Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293469984> ?p ?o ?g. }
- W4293469984 endingPage "3699" @default.
- W4293469984 startingPage "3685" @default.
- W4293469984 abstract "Pharmaceutical amorphous solid dispersions (ASDs) represent a widely used technology to increase the bioavailability of active pharmaceutical ingredients (APIs). ASDs are based on an amorphous API dispersed in a polymer, and their stability is driven by the presence of strong intermolecular interactions between these two species (e.g., hydrogen bond, electrostatic interactions, etc.). The understanding of these interactions at the atomic level is therefore crucial, and solid-state nuclear magnetic resonance (NMR) has demonstrated itself as a very powerful technique for probing API-polymer interactions. Other reviews have also reported exciting approaches to study the structures and dynamic properties of ASDs and largely focused on the study of API-polymer miscibility and on the identification of API-polymer interactions. Considering the increased use of NMR in the field, the aim of this Review is to specifically highlight recent experimental strategies used to identify API-polymer interactions and report promising recent examples using one-dimensional (1D) and two-dimensional (2D) experiments by exploiting the following emerging approaches of very-high magnetic field and ultrafast magic angle spinning (MAS). A range of different ASDs spanning APIs and polymers with varied structural motifs is targeted to illustrate new ways to understand the mechanism of stability of ASDs to enable the design of new dispersions." @default.
- W4293469984 created "2022-08-29" @default.
- W4293469984 creator A5009752801 @default.
- W4293469984 creator A5017162721 @default.
- W4293469984 creator A5019002599 @default.
- W4293469984 creator A5019267444 @default.
- W4293469984 creator A5048971428 @default.
- W4293469984 date "2022-08-29" @default.
- W4293469984 modified "2023-10-16" @default.
- W4293469984 title "New Development in Understanding Drug–Polymer Interactions in Pharmaceutical Amorphous Solid Dispersions from Solid-State Nuclear Magnetic Resonance" @default.
- W4293469984 cites W1482818487 @default.
- W4293469984 cites W1543696264 @default.
- W4293469984 cites W1824385695 @default.
- W4293469984 cites W1970599354 @default.
- W4293469984 cites W1984009385 @default.
- W4293469984 cites W1990417072 @default.
- W4293469984 cites W1991182147 @default.
- W4293469984 cites W1998647396 @default.
- W4293469984 cites W2027369785 @default.
- W4293469984 cites W2031427361 @default.
- W4293469984 cites W2037959733 @default.
- W4293469984 cites W2040518011 @default.
- W4293469984 cites W2041177590 @default.
- W4293469984 cites W2041517295 @default.
- W4293469984 cites W2046984650 @default.
- W4293469984 cites W2048830154 @default.
- W4293469984 cites W2057302487 @default.
- W4293469984 cites W2066654247 @default.
- W4293469984 cites W2069291979 @default.
- W4293469984 cites W2073456732 @default.
- W4293469984 cites W2084331387 @default.
- W4293469984 cites W2115682140 @default.
- W4293469984 cites W2149224872 @default.
- W4293469984 cites W2154804998 @default.
- W4293469984 cites W2202134586 @default.
- W4293469984 cites W2209586872 @default.
- W4293469984 cites W2253675932 @default.
- W4293469984 cites W2269901170 @default.
- W4293469984 cites W2275944058 @default.
- W4293469984 cites W2279863142 @default.
- W4293469984 cites W2304404543 @default.
- W4293469984 cites W2313140442 @default.
- W4293469984 cites W2330401612 @default.
- W4293469984 cites W2409807219 @default.
- W4293469984 cites W2523300513 @default.
- W4293469984 cites W2570486811 @default.
- W4293469984 cites W2616272147 @default.
- W4293469984 cites W2739920947 @default.
- W4293469984 cites W2742595555 @default.
- W4293469984 cites W2767187922 @default.
- W4293469984 cites W2768128512 @default.
- W4293469984 cites W2768832526 @default.
- W4293469984 cites W2792298858 @default.
- W4293469984 cites W2805425526 @default.
- W4293469984 cites W2808432932 @default.
- W4293469984 cites W2836932113 @default.
- W4293469984 cites W286837537 @default.
- W4293469984 cites W2899627234 @default.
- W4293469984 cites W2908611830 @default.
- W4293469984 cites W2940931984 @default.
- W4293469984 cites W2943094384 @default.
- W4293469984 cites W2981485464 @default.
- W4293469984 cites W2995177368 @default.
- W4293469984 cites W2997119786 @default.
- W4293469984 cites W2999264118 @default.
- W4293469984 cites W3020867979 @default.
- W4293469984 cites W3021244569 @default.
- W4293469984 cites W3025372730 @default.
- W4293469984 cites W3029619357 @default.
- W4293469984 cites W3034563477 @default.
- W4293469984 cites W3048277955 @default.
- W4293469984 cites W3095477892 @default.
- W4293469984 cites W3112181227 @default.
- W4293469984 cites W3127661501 @default.
- W4293469984 cites W3136009117 @default.
- W4293469984 cites W3163479728 @default.
- W4293469984 cites W3169596185 @default.
- W4293469984 cites W3182145277 @default.
- W4293469984 cites W3190589259 @default.
- W4293469984 cites W3215529596 @default.
- W4293469984 cites W4235577607 @default.
- W4293469984 cites W4241866359 @default.
- W4293469984 cites W4243077175 @default.
- W4293469984 cites W4281480446 @default.
- W4293469984 cites W64041536 @default.
- W4293469984 doi "https://doi.org/10.1021/acs.molpharmaceut.2c00479" @default.
- W4293469984 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36037249" @default.
- W4293469984 hasPublicationYear "2022" @default.
- W4293469984 type Work @default.
- W4293469984 citedByCount "7" @default.
- W4293469984 countsByYear W42934699842023 @default.
- W4293469984 crossrefType "journal-article" @default.
- W4293469984 hasAuthorship W4293469984A5009752801 @default.
- W4293469984 hasAuthorship W4293469984A5017162721 @default.
- W4293469984 hasAuthorship W4293469984A5019002599 @default.
- W4293469984 hasAuthorship W4293469984A5019267444 @default.
- W4293469984 hasAuthorship W4293469984A5048971428 @default.
- W4293469984 hasBestOaLocation W42934699842 @default.